INSPIREMD, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.382 USD | -0.75% |
|
+12.36% | -15.23% |
| 14/05 | Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M | MT |
| 06/03 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3.923 | 12.6 | 24.39 | 7.164 | 60.13 | 55.8 | - | - |
| Enterprise Value (EV) 1 | 3.923 | 12.6 | 24.39 | 7.164 | 60.13 | 55.8 | 55.8 | 55.8 |
| P/E ratio | - | -0.74 x | -1.49 x | -0.37 x | -3.43 x | - | - | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.05 x | 5.07 x | 5.43 x | 1.39 x | 9.69 x | 7.87 x | 3.81 x | 1.77 x |
| EV / Revenue | 1.05 x | 5.07 x | 5.43 x | 1.39 x | 9.69 x | 7.87 x | 3.81 x | 1.77 x |
| EV / EBITDA | - | - | - | - | -3.66 x | -2.69 x | -2.02 x | -2.16 x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 242 | 2,464 | 8,077 | 8,336 | 21,400 | 23,424 | - | - |
| Reference price 2 | 16.20 | 5.113 | 3.020 | 0.8595 | 2.810 | 2.382 | 2.382 | 2.382 |
| Announcement Date | 10/03/20 | 08/03/21 | 07/03/22 | 30/03/23 | 05/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3.721 | 2.485 | 4.495 | 5.171 | 6.205 | 7.094 | 14.65 | 31.54 |
| EBITDA 1 | - | - | - | - | -16.42 | -20.72 | -27.64 | -25.85 |
| EBIT 1 | -9.816 | -10.38 | -14.72 | - | -21.14 | -24.96 | -32.69 | -31.73 |
| Operating Margin | -263.8% | -417.71% | -327.39% | - | -340.74% | -351.83% | -223.23% | -100.61% |
| Earnings before Tax (EBT) | - | -10.54 | -14.87 | - | -19.85 | - | - | - |
| Net income | - | -10.54 | -14.92 | - | -19.92 | - | - | - |
| Net margin | - | -424.31% | -331.88% | - | -320.97% | - | - | - |
| EPS | - | -6.900 | -2.030 | -2.350 | -0.8200 | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 10/03/20 | 08/03/21 | 07/03/22 | 30/03/23 | 05/03/24 | - | - | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1.38 | 1.183 | 1.531 | 1.431 | 1.026 | 1.239 | 1.649 | 1.556 | 1.761 | 1.511 | 1.876 | 1.69 | 2.144 | 2.35 | 3.303 |
| EBITDA 1 | - | - | - | - | - | - | -5.257 | -5.581 | -4.098 | -7.345 | -5.193 | -4.563 | -6.689 | -5.903 | -6.825 |
| EBIT 1 | -3.931 | -4.486 | -4.681 | -4.61 | - | -4.381 | -5.315 | -5.639 | -5.808 | -7.414 | -6.256 | -5.626 | -7.739 | -7.168 | -8.093 |
| Operating Margin | -284.86% | -379.21% | -305.75% | -322.15% | - | -353.59% | -322.32% | -362.4% | -329.81% | -490.67% | -333.48% | -332.9% | -360.96% | -305.02% | -245.02% |
| Earnings before Tax (EBT) | -4.052 | -4.481 | -4.636 | -4.529 | - | -4.256 | -5.077 | -5.178 | -5.34 | - | - | - | - | - | - |
| Net income | -4.097 | -4.481 | -4.636 | -4.529 | - | -4.256 | -5.077 | -5.178 | -5.405 | - | - | - | - | - | - |
| Net margin | -296.88% | -378.78% | -302.81% | -316.49% | - | -343.5% | -307.88% | -332.78% | -306.93% | - | - | - | - | - | - |
| EPS | -0.5300 | -0.5700 | -0.5900 | -0.5800 | -0.6000 | -0.5300 | -0.2400 | -0.1500 | -0.1300 | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 07/03/22 | 09/05/22 | 08/08/22 | 07/11/22 | 30/03/23 | 15/05/23 | 07/08/23 | 06/11/23 | 05/03/24 | 13/05/24 | - | - | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - | - |
| Announcement Date | 10/03/20 | 08/03/21 | 07/03/22 | 30/03/23 | 05/03/24 | - | - | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.382
USD
Average target price
4.5
USD
Spread / Average Target
+88.92%
| 1st Jan change | Capi. | |
|---|---|---|
| -15.23% | 55.8M | |
| -5.51% | 181B | |
| +2.33% | 112B | |
| -3.62% | 67.92B | |
| +1.52% | 50.1B | |
| +8.06% | 44.27B | |
| +9.39% | 40.41B | |
| +23.35% | 31.95B | |
| +0.67% | 25.82B | |
| +17.27% | 25.29B |
- Stock Market
- Equities
- NSPR Stock
- Financials InspireMD, Inc.